<DOC>
	<DOC>NCT02186041</DOC>
	<brief_summary>The purpose of this study is to document the safety, the effectiveness, the continued performance at mid and long term, the morbidity and the percent of surgical revisions of the Interstim® therapy for up to 5 years in a representative sample of French centers under real-life conditions of use.</brief_summary>
	<brief_title>Sacral Neuromodulation With InterStim® Therapy for Intractable Urinary Voiding Dysfunctions (SOUNDS): an Observational Study</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Retention</mesh_term>
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<criteria>Patient is at least 18 years old; Patient signed the Patient Data Release Form; Patient suffering from retention or Over Active Bladder; Patient is eligible for Interstim® system therapy. Difficulty of collecting follow up patient data; Patient not affiliated to social security.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>